参考文献:[1]张倩倩,解文君,刘亚婷,等. Ph阴性骨髓增殖性肿瘤临床护理实践指南的整合[J]. 中华现代护理杂志,2023,29(15):2055-2062.DOI:10.3760/cma.j.cn115682-20221123-05656[2]王彬彬,唐古生.长效干扰素在费城染色体阴性骨髓增殖性肿瘤中的研究进展[J].白血病·淋巴瘤, 2023(10).DOI:10.3760/cma.j.cn115356-20220615-00172.[3]Alvarez ‑ Larrán A,Kerguelen A,Hernández ‑ Boluda JC,et al.Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera[J].Br J Haematol,2016,172(5):786‑793.DOI:10.1111/bjh.13886[4]Hasselbalch HC,Silver RT. New Perspectives of interferon alpha2 and inflammation in treating philadelphia negative chronic myeloproliferative neoplasms[J]. Hemasphere,2021,5(12):e645. DOI:10.1097/HS9.0000000000000645.